Non‐mnestic cognitive function in the scopolamine model of Alzheimer's Disease

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Human Psychopharmacology: Clinical and Experimental

• Publication date

  1998-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/(SICI)1099-1077(199808)13:6<439::AID-HUP19>3.0.CO;2-E
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropsychiatric aspects of alzheimer’s disease

  1999cited by this paper
• Functional activation of cerebral blood flow abolished by scopolamine is reversed by cognitive enhancers associated with cholinesterase inhibition: a positron emission tomography study in unanesthetized monkeys.

  1997cited by this paper
• Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease.

  1997cited by this paper
• The cholinergic system in Alzheimer's disease.

  1997cited by this paper
• The effects of scopolamine on the recall of repeated words: a preliminary investigation

  1996cited by this paper
• Effects of anticholinesterase drugs tacrine and E2020, the 5-HT(3) antagonist ondansetron, and the H(3) antagonist thioperamide, in models of cognition and cholinergic function.

  1996cited by this paper
• Ageing: the cholinergic hypothesis of cognitive decline.

  1995cited by this paper
• Quantitative assessment of movement in Alzheimer's disease.

  1995cited by this paper
• Effects of cholinergic blockade on language in healthy young women. Implications for the cholinergic hypothesis in dementia of the Alzheimer type.

  1994influential reference
• Tacrine for Alzheimer's disease.

  1994cited by this paper
• A quantitative review of the diagnostic utility of the WAIS-R Fuld profile.

  1993cited by this paper
• Further evidence that scopolamine can improve verbal fluency

  1993cited by this paper
• Utility of a modified version of the wisconsin card sorting test in the detection of dementia of the alzheimer type.

  1993cited by this paper
• Cerebral blood flow in Alzheimer's disease imaged by Positron Emission Tomography: the effects of physostigmine infusion

  1992cited by this paper
• Cholinergic 'blockade' as a model of the cognitive deficits in Alzheimer's disease.

  1992cited by this paper
• Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model.

  1992influential reference
• A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.

  1992cited by this paper
• Longitudinal sensitivity of the Fuld cholinergic profile to Alzheimer's disease.

  1992cited by this paper
• Activation to Acquisition: Functional Aspects of the Basal Forebrain Cholinergic System

  1991cited by this paper
• The effects of THA on scopolamine and nucleus basalis lesion-induced EEG slowing.

  1991cited by this paper
• The WAIS-R profile as a cognitive marker of Alzheimer's disease: a misguided venture?

  1991cited by this paper
• The effects of scopolamine on retrieval from semantic memory

  1991cited by this paper
• Tacrine: a pharmacological review.

  1991cited by this paper
• Anticholinergic challenge and cognitive functions: a comparison between young and elderly normal subjects.

  1991cited by this paper
• Cholinergic grafts, memory and ageing.

  1991cited by this paper
• Incidence of the WAIS-R Fuld profile in HIV-1 infection.

  1990cited by this paper
• Line orientation judgment in normal elderly and subjects with dementia of Alzheimer's type.

  1990cited by this paper
• Scopolamine and sustained retrieval from semantic memory

  1990influential reference
• Dementia: the role of neurotransmitter deficits

  1990cited by this paper
• A WAIS-R marker for accelerated aging and dementia, Alzheimer's type? Base rates of the Fuld formula in the WAIS-R standardization sample.

  1990cited by this paper
• Neurochemical aspects on aging and diseases with cognitive impairment

  1990cited by this paper
• Atropine, scopolamine and related antimuscarinic drugs

  1990influential reference
• Frequency of occurrence of a WAIS dementia pattern in schizophrenia and bipolar affective disorder

  1989cited by this paper
• Behavioral neuroanatomy of cholinergic innervation in the primate cerebral cortex.

  1989cited by this paper
• Aphasia in senile dementia of the alzheimer type

  1988cited by this paper
• Modelling dementia: effects of scopolamine on memory and attention.

  1988cited by this paper
• Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome.

  1988influential reference
• Modified wisconsin sorting test in elderly normal, depressed and demented patients

  1988cited by this paper
• Language in dementia part I: A review

  1987cited by this paper
• Wechsler intelligence scale profiles, the cholinergic system, and alzheimer's disease

  1987cited by this paper
• Age‐related shrinkage of cortically projecting cholinergic neurons: A selective effect

  1987cited by this paper
• Central cholinergic deficiency WAIS profiles in a nondemented aged sample.

  1987cited by this paper
• Frequency of occurrence of a WAIS dementia profile in male head trauma patients.

  1987cited by this paper
• Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study.

  1987influential reference
• WAIS-R marker for dementia of the Alzheimer type? An empirical and statistical induction test.

  1987cited by this paper
• Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia.

  1986influential reference
• Neuropsychologic detection of abnormal mental decline in older persons.

  1985cited by this paper
• Language and aging.

  1985influential reference
• Language in Dementia

  1985influential reference
• Effects of aging on rat cortical presynaptic cholinergic processes.

  1984cited by this paper
• Verbal fluency as a function of a measure of verbal intelligence and in relation to different types of cerebral pathology.

  1984cited by this paper
• Cellular ageing: selective vulnerability of cholinergic neurones in human brain.

  1984cited by this paper
• Test profile of cholinergic dysfunction and of Alzheimer-type dementia.

  1984influential reference
• Classification of dementia patients by a WAIS profile related to central cholinergic deficiencies.

  1984cited by this paper
• Standard Progressive Matrices

  1984cited by this paper
• Alzheimer's disease: a disorder of cortical cholinergic innervation.

  1983cited by this paper
• Visuoperceptual performances in aging and dementia: clinical and theoretical implications.

  1983cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper
• The National Adult Reading Test

  1982cited by this paper
• Aging Decreases Oxidative Metabolism and the Release and Synthesis of Acetylcholine

  1981cited by this paper
• Verbal fluency in aging and dementia

  1980cited by this paper
• Cholinergic receptor loss in brains of aging mice.

  1980cited by this paper
• The effects and interactions of scopolamine, physostigmine and methamphetamine on human memory.

  1979cited by this paper
• Loss of choline acetyltransferase activity in normal aging and in senile dementia.

  1978cited by this paper
• A modified card sorting test sensitive to frontal lobe defects.

  1976cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Human memory and the cholinergic system. A relationship to aging?

  1974influential reference
• THE ASSESSMENT OF APHASIA AND RELATED DISORDERS

  1973cited by this paper
• The Assessment of Aphasia and Related Disorders

  1973cited by this paper
• Memory impairment in the aged: storage versus retrieval deficit.

  1972cited by this paper
• The central effects of scopolamine in man.

  1971cited by this paper
• A short form of the token test.

  1969cited by this paper

• Neuropsychological, neurological and psychiatric implications in a case of poisoning scopolamine

  2013cites this paper
• Why people see things that are not there: A novel Perception and Attention Deficit model for recurrent complex visual hallucinations

  2005cites this paper
• An evaluation of methods of estimating premorbid ability

  1999cites this paper